| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000026368 |
| Receipt No. | R000029836 |
| Official scientific title of the study | The study of sleep apnea syndrome with nasal obstruction |
| Date of disclosure of the study information | 2017/03/02 |
| Last modified on | 2017/03/08 (Ver. 2) |
| Basic information | ||
| Official scientific title of the study | The study of sleep apnea syndrome with nasal obstruction | |
| Title of the study (Brief title) | The study of nasal obstruction | |
| Region |
|
|
| Condition | |||
| Condition | Sleep apnea syndrome | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | Nasal obstruction frequently has been associated with worsening the treatment for sleep apnea syndrome(SAS). We examined the two types of treatment for allergic rhinitis with SAS, and in a future this study will be useful for nasal obstruction of SAS. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | Others |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | 1.The chages of nasal obstruction in patients with OSAS after treatment
2.Serum total IgE, RAST 3.The persistence of CPAP treatment (using time etc.) 4.The questionnaire of Pittsburg Sleep Quality Index(PSQI) 5.Epworth sleepness scale(ESS) |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Single blind -participants are blinded |
| Control | Active |
| Stratification | NO |
| Dynamic allocation | NO |
| Institution consideration | Institution is not considered as adjustment factor. |
| Blocking | NO |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | The following each treatment for 14days
1.Fexofenadine Hydrochloride(60mg) twice daily |
|
| Interventions/Control_2 | 2.Fexofenadine Hydrochloride(60mg)/ Pseudiephedrine Hydrochloride(120mg) Combination Tablets twice daily | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | The patients who diagnosed with SAS and started CPAP therapy have nasal obstruction for allergic rhinitis. | |||
| Key exclusion criteria | severe nasal septal space disease
severe nasal polyps severe nasal tumor Uncontrolled hypertension Severe coronary artery disease Narrow angle glaucoma |
|||
| Target sample size | 100 | |||
| Research contact person | |
| Name of lead principal investigator | Koichi Fukunaga |
| Organization | Department of Medicine, Keio University School of Medicine |
| Division name | Pulmonary Medicine |
| Address | 35 shinanomochi shinjyuku-ku, Tokyo, JAPAN |
| TEL | 0333531211 |
| k-fuku@jf7.so-net.ne.jp | |
| Public contact | |
| Name of contact person | Wakako Yamasawa |
| Organization | Department of Medicine, Keio University School of Medicine |
| Division name | Pulmonary Medicine |
| Address | 35 shinanomochi shinjyuku-ku, Tokyo, JAPAN |
| TEL | 0333531211 |
| Homepage URL | http://www.keio-med.jp/pulmonary/ |
| wakako@df6.so-net.ne.jp | |
| Sponsor | |
| Institute | Department of Medicine, Keio University School of Medicine |
| Institute | |
| Department | |
| Funding Source | |
| Organization | no |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | no |
| Other related organizations | |
| Co-sponsor | Nippon Koukan Hospital
Kitasato University Kitasato Institute Hospital Shinjyuku Sleep Medical Clinic Kichijyoji Sleep Medical Clinic RESM Sleep Respiratory Medicalcareclinic |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 慶應義塾大学病院 |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000029836 |